Immediate Impact
3 by Nobel laureates 1 from Science/Nature 51 standout
Citing Papers
Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin-treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, non-inferiority trial
2023 Standout
Once-Weekly Insulin Icodec vs Once-Daily Insulin Degludec in Adults With Insulin-Naive Type 2 Diabetes
2023 Standout
Works of Daniel Wierda being referenced
Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products
2004
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Daniel Wierda | 461 | 287 | 311 | 23 | 842 | |
| Andreas Baumann | 184 | 298 | 185 | 31 | 858 | |
| Winston Evering | 306 | 172 | 77 | 21 | 686 | |
| Jacintha Shenton | 177 | 251 | 224 | 18 | 735 | |
| R. W. Baldwin | 282 | 208 | 183 | 33 | 946 | |
| B. Fox | 322 | 201 | 167 | 38 | 786 | |
| Kerstin Müller | 149 | 235 | 207 | 25 | 702 | |
| Gerald W. King | 249 | 184 | 60 | 16 | 668 | |
| Tokio Kaizu | 156 | 478 | 161 | 22 | 765 | |
| Barbara C. Millar | 162 | 286 | 106 | 36 | 946 | |
| S Nishi | 348 | 369 | 113 | 35 | 964 |
All Works
Loading papers...